243 related articles for article (PubMed ID: 17672443)
1. Structure-activity relationship of 2-oxoamide inhibition of group IVA cytosolic phospholipase A2 and group V secreted phospholipase A2.
Six DA; Barbayianni E; Loukas V; Constantinou-Kokotou V; Hadjipavlou-Litina D; Stephens D; Wong AC; Magrioti V; Moutevelis-Minakakis P; Baker SF; Dennis EA; Kokotos G
J Med Chem; 2007 Aug; 50(17):4222-35. PubMed ID: 17672443
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of group IVA cytosolic phospholipase A2 by novel 2-oxoamides in vitro, in cells, and in vivo.
Kokotos G; Six DA; Loukas V; Smith T; Constantinou-Kokotou V; Hadjipavlou-Litina D; Kotsovolou S; Chiou A; Beltzner CC; Dennis EA
J Med Chem; 2004 Jul; 47(14):3615-28. PubMed ID: 15214789
[TBL] [Abstract][Full Text] [Related]
3. Distinguishing phospholipase A2 types in biological samples by employing group-specific assays in the presence of inhibitors.
Lucas KK; Dennis EA
Prostaglandins Other Lipid Mediat; 2005 Sep; 77(1-4):235-48. PubMed ID: 16099408
[TBL] [Abstract][Full Text] [Related]
4. Novel 2-oxoamide inhibitors of human group IVA phospholipase A(2).
Kokotos G; Kotsovolou S; Six DA; Constantinou-Kokotou V; Beltzner CC; Dennis EA
J Med Chem; 2002 Jul; 45(14):2891-3. PubMed ID: 12086476
[TBL] [Abstract][Full Text] [Related]
5. 2-Oxoamides based on dipeptides as selective calcium-independent phospholipase A
Smyrniotou A; Kokotou MG; Mouchlis VD; Barbayianni E; Kokotos G; Dennis EA; Constantinou-Kokotou V
Bioorg Med Chem; 2017 Feb; 25(3):926-940. PubMed ID: 28034646
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of 2-oxoamides based on sulfonamide analogs of gamma-amino acids and their activity on phospholipase A2.
Antonopoulou G; Magrioti V; Stephens D; Constantinou-Kokotou V; Dennis EA; Kokotos G
J Pept Sci; 2008 Oct; 14(10):1111-20. PubMed ID: 18618424
[TBL] [Abstract][Full Text] [Related]
7. 2-Oxoamide inhibitors of cytosolic group IVA phospholipase A2 with reduced lipophilicity.
Antonopoulou G; Magrioti V; Kokotou MG; Nikolaou A; Barbayianni E; Mouchlis VD; Dennis EA; Kokotos G
Bioorg Med Chem; 2016 Oct; 24(19):4544-4554. PubMed ID: 27522578
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity relationships of natural and non-natural amino acid-based amide and 2-oxoamide inhibitors of human phospholipase A(2) enzymes.
Antonopoulou G; Barbayianni E; Magrioti V; Cotton N; Stephens D; Constantinou-Kokotou V; Dennis EA; Kokotos G
Bioorg Med Chem; 2008 Dec; 16(24):10257-69. PubMed ID: 18993078
[TBL] [Abstract][Full Text] [Related]
9. Differential inhibition of group IVA and group VIA phospholipases A2 by 2-oxoamides.
Stephens D; Barbayianni E; Constantinou-Kokotou V; Peristeraki A; Six DA; Cooper J; Harkewicz R; Deems RA; Dennis EA; Kokotos G
J Med Chem; 2006 May; 49(9):2821-8. PubMed ID: 16640343
[TBL] [Abstract][Full Text] [Related]
10. New potent and selective polyfluoroalkyl ketone inhibitors of GVIA calcium-independent phospholipase A2.
Magrioti V; Nikolaou A; Smyrniotou A; Shah I; Constantinou-Kokotou V; Dennis EA; Kokotos G
Bioorg Med Chem; 2013 Sep; 21(18):5823-9. PubMed ID: 23916152
[TBL] [Abstract][Full Text] [Related]
11. A novel role for phospholipase A2 isoforms in the checkpoint control of acute inflammation.
Gilroy DW; Newson J; Sawmynaden P; Willoughby DA; Croxtall JD
FASEB J; 2004 Mar; 18(3):489-98. PubMed ID: 15003994
[TBL] [Abstract][Full Text] [Related]
12. Discovery of Ecopladib, an indole inhibitor of cytosolic phospholipase A2alpha.
Lee KL; Foley MA; Chen L; Behnke ML; Lovering FE; Kirincich SJ; Wang W; Shim J; Tam S; Shen MW; Khor S; Xu X; Goodwin DG; Ramarao MK; Nickerson-Nutter C; Donahue F; Ku MS; Clark JD; McKew JC
J Med Chem; 2007 Mar; 50(6):1380-400. PubMed ID: 17305324
[TBL] [Abstract][Full Text] [Related]
13. Cytosolic phospholipase A2 inhibition attenuates ischemia-reperfusion injury in an isolated rat lung model.
Bellido-Reyes YA; Akamatsu H; Kojima K; Arai H; Tanaka H; Sunamori M
Transplantation; 2006 Jun; 81(12):1700-7. PubMed ID: 16794537
[TBL] [Abstract][Full Text] [Related]
14. Computer-aided drug design guided by hydrogen/deuterium exchange mass spectrometry: A powerful combination for the development of potent and selective inhibitors of Group VIA calcium-independent phospholipase A
Mouchlis VD; Morisseau C; Hammock BD; Li S; McCammon JA; Dennis EA
Bioorg Med Chem; 2016 Oct; 24(20):4801-4811. PubMed ID: 27320659
[TBL] [Abstract][Full Text] [Related]
15. 2-Oxoesters: A Novel Class of Potent and Selective Inhibitors of Cytosolic Group IVA Phospholipase A
Kokotou MG; Galiatsatou G; Magrioti V; Koutoulogenis G; Barbayianni E; Limnios D; Mouchlis VD; Satpathy B; Navratil A; Dennis EA; Kokotos G
Sci Rep; 2017 Aug; 7(1):7025. PubMed ID: 28765606
[TBL] [Abstract][Full Text] [Related]
16. Spinal phospholipase A2 in inflammatory hyperalgesia: role of group IVA cPLA2.
Lucas KK; Svensson CI; Hua XY; Yaksh TL; Dennis EA
Br J Pharmacol; 2005 Apr; 144(7):940-52. PubMed ID: 15685208
[TBL] [Abstract][Full Text] [Related]
17. Suppression of inflammatory responses by surfactin, a selective inhibitor of platelet cytosolic phospholipase A2.
Kim K; Jung SY; Lee DK; Jung JK; Park JK; Kim DK; Lee CH
Biochem Pharmacol; 1998 Apr; 55(7):975-85. PubMed ID: 9605421
[TBL] [Abstract][Full Text] [Related]
18. Binding conformation of 2-oxoamide inhibitors to group IVA cytosolic phospholipase A2 determined by molecular docking combined with molecular dynamics.
Mouchlis VD; Michopoulou V; Constantinou-Kokotou V; Mavromoustakos T; Dennis EA; Kokotos G
J Chem Inf Model; 2012 Jan; 52(1):243-54. PubMed ID: 22196172
[TBL] [Abstract][Full Text] [Related]
19. Intracerebroventricular injection of phospholipases A2 inhibitors modulates allodynia after facial carrageenan injection in mice.
Yeo JF; Ong WY; Ling SF; Farooqui AA
Pain; 2004 Nov; 112(1-2):148-55. PubMed ID: 15494195
[TBL] [Abstract][Full Text] [Related]
20. Inhibitors of secreted phospholipase A2 suppress the release of PGE2 in renal mesangial cells.
Vasilakaki S; Barbayianni E; Magrioti V; Pastukhov O; Constantinou-Kokotou V; Huwiler A; Kokotos G
Bioorg Med Chem; 2016 Jul; 24(13):3029-3034. PubMed ID: 27234891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
